Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 10.23 Exhibit 10.23
- 10.24 Exhibit 10.24
- 10.25 Exhibit 10.25
- 10.26 Exhibit 10.26
- 10.27 Exhibit 10.27
- 10.28 Exhibit 10.28
- 10.29 Exhibit 10.29
- 10.30 Exhibit 10.30
- 10.31 Exhibit 10.31
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.5 Exhibit 99.5
- 99.8 Exhibit 99.8
- EX-FILING FEES Exhibit Filing Fees
Associated filings
- 14 Jul 23 EFFECT Notice of effectiveness
- 13 Jul 23 424B3 Prospectus supplement
- 11 Jul 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 22 Jun 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
10 May 23 S-4 Registration of securities issued in business combination transactions
CRVO similar filings
Filing view
External links
Exhibit 99.4
DIRECTOR CONSENT
I hereby consent to serve as a director of Diffusion Pharmaceuticals Inc. (the “Company”), if elected as such, and to be named as a nominee or potential nominee for director of the Company in any registration statement filed by the Company under the Securities Act of 1933, as amended, including all amendments and post-effective amendments or supplements thereto and any prospectus and/or proxy statement contained therein.
/s/ Marwan Sabbagh, M.D. | ||
Name: | Marwan Sabbagh, M.D. | |
Date: | May 10, 2023 |